NICE technology appraisal guidance
Issued: November 2010
TA208

Trastuzumab for the treatment of HER2-positive metastatic gastric cancer

This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta208

6 Related NICE guidance

  • Capecitabine for the treatment of advanced gastric cancer.NICE technology appraisal guidance 191 (2010). Available from www.nice.org.uk/guidance/TA191